On the frontiers of technology, some ideas sound outlandish yet quietly reshape the world. In a January 30, 2026 report, MIT Technology Review journalist Jessica Hamzelou explores how the "sometimes bizarre" world of life extension is gaining influence. This group believes death is not a natural law but a "core problem" humanity must solve. They even claim death is morally wrong and have founded the philosophy of "Vitalism." This emerging trend is moving from Silicon Valley labs to a global investment boom.
The Birth and Core Tenets of Vitalism
Vitalism is not traditional philosophy but a radical rebellion against death. Its founders include tech billionaires and biologists who view aging as a reversible disease, not an inevitable force. Simply put, Vitalism holds that life should last indefinitely and that death is a result of technical failure. This concept stems from Longevity Escape Velocity but adds a moral dimension — they believe allowing death is equivalent to condoning injustice.
'Death is the "core problem" for humanity. In short, they say death is wrong — wrong for everyone. And they even say it is morally wrong.' — Excerpt from the article
This philosophy has moved beyond rhetoric. In the early 2020s, Vitalism supporters established foundations to advance research. For instance, Bryan Johnson's "Blueprint" project spends millions annually optimizing his own biomarkers, claiming to have reversed his biological age by five years. Similar projects include Peter Thiel-backed Unity Biotechnology, which focuses on clearing senescent cells (senolytics).
The Investment Boom and Industry Context of Longevity Technology
Life extension is not a new topic. In 2013, Google founded Calico Labs with the explicit goal of "curing aging." Jeff Bezos and Yuri Milner invested $3 billion in 2021 to launch Altos Labs, recruiting Nobel laureates such as Shinya Yamanaka to advance induced pluripotent stem cell (iPS) technology. By 2025, the field had raised over $100 billion in funding, spanning gene editing (CRISPR), epigenetic clock reprogramming, and nanorobots.
China is catching up: Beike founder Zuo Hui invested in longevity startups, and Tsinghua University is advancing aging biology. The global market is projected to reach trillions by 2030, with pharmaceutical giants like Novartis and Roche entering the space. The rise of Vitalism is consolidating these scattered efforts into a movement.
Key Figures: From Silicon Valley Billionaires to Scientific Pioneers
Among the group Jessica Hamzelou tracks, Bryan Johnson is the most representative. He tracks his health metrics publicly through strict diet, exercise, and drug interventions. Another is Aubrey de Grey, founder of the SENS Foundation, who proposes strategies to repair the "seven major types of aging damage." Laura Deming's Longevity Fund has invested in dozens of startups.
The influence of these figures is growing. In 2025, the Davos Forum hosted a longevity session, and Bill Gates publicly supported the cause. Vitalism is even impacting policy: the EU funds a "Healthspan 100 Years" program, and the U.S. FDA is accelerating approval of aging-related drugs.
Scientific Progress: From Labs to Clinical Trials
On the technical front, progress is promising. Yamanaka factor reprogramming has reversed aging in mice, and human trials have begun. NAD+ supplements like NMN are already sold over the counter in Asia. AI is accelerating drug discovery: Insilico Medicine uses generative AI to design senolytic drugs, now in Phase II trials. Organ chips and 3D bioprinting are addressing transplant bottlenecks.
However, challenges remain. In 2024, a long-term trial of rapamycin revealed side effects, sparking debate. While epigenetic clocks accurately measure biological age, the reversal mechanisms remain unclear.
Controversies and Ethical Dilemmas
The world of Vitalism can be "bizarre": Johnson's "blood boy" experiment and rumors of billionaires hoarding young blood have raised ethical questions. Critics argue this exacerbates inequality — longevity technology could become a privilege of the elite. The societal impact is even deeper: infinite lifespans would reshape economics, retirement, and views on reproduction.
On a philosophical level, death gives life meaning. Does Vitalism strip away humanity? In Hamzelou's report, one supporter responds: "If you don't solve death, all other problems are meaningless."
Editor's Note: The Far-Reaching Impact of Vitalism
As an AI tech news editor, I believe Vitalism marks a paradigm shift from "accepting fate" to "remaking biology." Though bizarre, it gains legitimacy through waves of AI and genomics. In the next decade, longevity may become mainstream, but balancing ethics and accessibility is crucial. Ignoring it would mean missing an opportunity to reshape society.
In summary, life extension is moving from science fiction to reality, and the influence of Vitalism will continue to grow. Is humanity ready for an era of immortality?
This article is compiled from MIT Technology Review.
© 2026 Winzheng.com 赢政天下 | 转载请注明来源并附原文链接